AU2002232392A1 - Preferred segments of Neural Thread Protein and methods of using the same - Google Patents

Preferred segments of Neural Thread Protein and methods of using the same

Info

Publication number
AU2002232392A1
AU2002232392A1 AU2002232392A AU3239202A AU2002232392A1 AU 2002232392 A1 AU2002232392 A1 AU 2002232392A1 AU 2002232392 A AU2002232392 A AU 2002232392A AU 3239202 A AU3239202 A AU 3239202A AU 2002232392 A1 AU2002232392 A1 AU 2002232392A1
Authority
AU
Australia
Prior art keywords
peptide
ntp
arl
amino acid
harlil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232392A
Other languages
English (en)
Inventor
Paul Averback
Riza Bibiano
Judith Fitzpatrick
Ma. Soledad S. Focht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nymox Corp Canada
Original Assignee
NYMOX PHARMACEUTICALS CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NYMOX PHARMACEUTICALS CORP filed Critical NYMOX PHARMACEUTICALS CORP
Publication of AU2002232392A1 publication Critical patent/AU2002232392A1/en
Priority to AU2007249077A priority Critical patent/AU2007249077A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002232392A 2000-10-27 2001-10-25 Preferred segments of Neural Thread Protein and methods of using the same Abandoned AU2002232392A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2007249077A AU2007249077A1 (en) 2000-10-27 2007-12-17 Preferred segments of neural thread protein and methods of using the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/697,590 US7259232B1 (en) 2000-10-27 2000-10-27 Preferred segments of neural thread protein
US09/697,590 2000-10-27
PCT/US2001/042813 WO2002034915A2 (en) 2000-10-27 2001-10-25 Preferred segments of neural thread protein and methods of using the same

Publications (1)

Publication Number Publication Date
AU2002232392A1 true AU2002232392A1 (en) 2002-05-06

Family

ID=24801714

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232392A Abandoned AU2002232392A1 (en) 2000-10-27 2001-10-25 Preferred segments of Neural Thread Protein and methods of using the same

Country Status (15)

Country Link
US (2) US7259232B1 (de)
EP (2) EP1702985A3 (de)
JP (1) JP2005512500A (de)
KR (1) KR100843792B1 (de)
CN (1) CN1492926A (de)
AT (1) ATE330011T1 (de)
AU (1) AU2002232392A1 (de)
BR (1) BR0114977A (de)
CA (1) CA2427070A1 (de)
CY (1) CY1105380T1 (de)
DE (1) DE60120782T2 (de)
DK (1) DK1379650T3 (de)
ES (1) ES2266296T3 (de)
PT (1) PT1379650E (de)
WO (1) WO2002034915A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002302239B2 (en) * 2000-10-27 2006-12-14 Nymox Corporation Method of preventing cell death using segments of neural thread proteins
KR20040008177A (ko) * 2001-05-16 2004-01-28 니목스 코포레이션 신경 사 단백질 세그먼트를 사용하여 세포 사멸을억제하는 방법
EP1541166B1 (de) * 2001-05-16 2007-12-19 Nymox Corporation Prävention des Zelltodes durch Verwendung von Segmenten der Neurofilamentproteinen
NZ529911A (en) * 2001-05-25 2008-05-30 Nymox Corp Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
US7544771B2 (en) * 2005-02-23 2009-06-09 Nymox Corporation Protein and its use in diagnosing Alzheimer's disease
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068375A3 (de) 1981-06-22 1983-04-13 G.D. Searle & Co. Rekombinante DNS Technik zur Herstellung von Relaxin
SE8300693L (sv) 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5084559A (en) 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
CA2006332C (en) 1988-12-21 2003-04-08 Suzanne De La Monte Method of detecting neurological disease or dysfunction
US5948634A (en) 1988-12-21 1999-09-07 The General Hospital Coporation Neural thread protein gene expression and detection of alzheimer's disease
KR100374449B1 (ko) * 1994-03-07 2003-09-06 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 효소를인코우드하는디엔에이(dna),재조합디엔에이(dna)와효소,형질전환체및이들의제조방법과용도
GB9422175D0 (en) 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
US5958416A (en) 1994-12-16 1999-09-28 Regents Of The University Of Minnesota Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
US6610506B1 (en) * 1995-12-01 2003-08-26 University Technologies International, Inc. Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
US6013763A (en) 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
WO1999016710A1 (en) 1997-09-30 1999-04-08 Cel-Sci Corporation Immunogenic conjugated polypeptide for treatment of herpes simplex virus
US6399075B1 (en) 1998-07-02 2002-06-04 President And Fellows Of Harvard College Compositions and methods for treating Papillomavirus-infected cells
JP2002542766A (ja) 1999-03-12 2002-12-17 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質
CA2368927A1 (en) 1999-03-26 2000-10-05 Craig A. Rosen 45 human secreted proteins
KR20040008177A (ko) 2001-05-16 2004-01-28 니목스 코포레이션 신경 사 단백질 세그먼트를 사용하여 세포 사멸을억제하는 방법

Also Published As

Publication number Publication date
US20090258426A1 (en) 2009-10-15
DE60120782T2 (de) 2007-05-24
EP1702985A3 (de) 2007-03-07
DK1379650T3 (da) 2006-10-23
JP2005512500A (ja) 2005-05-12
WO2002034915A3 (en) 2003-11-20
CY1105380T1 (el) 2010-04-28
KR100843792B1 (ko) 2008-07-03
BR0114977A (pt) 2006-05-09
KR20030067681A (ko) 2003-08-14
ATE330011T1 (de) 2006-07-15
DE60120782D1 (de) 2006-07-27
ES2266296T3 (es) 2007-03-01
EP1702985A2 (de) 2006-09-20
PT1379650E (pt) 2006-10-31
US7259232B1 (en) 2007-08-21
EP1379650A2 (de) 2004-01-14
CA2427070A1 (en) 2002-05-02
EP1379650B1 (de) 2006-06-14
CN1492926A (zh) 2004-04-28
WO2002034915A2 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
US20090258426A1 (en) Preferred segments of neural thread protein and method of using the same
US20230295283A1 (en) N-terminal truncated protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's
RU2416619C2 (ru) Способ in vitro-диагностики болезни альцгеймера с помощью моноклонального антитела
JP6420072B2 (ja) Ｎ−１１短縮化アミロイド−ベータモノクローナル抗体、組成物、方法および使用
US11919947B2 (en) Antibody binding active α-synuclein
WO2010011999A2 (en) Methods and compositions for eliciting an amyloid-selective immune response
JP4079775B2 (ja) β−アミロイドペプチドの可溶性環状類似体
Rostagno et al. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease
AU2007249077A1 (en) Preferred segments of neural thread protein and methods of using the same
WO2018078018A2 (en) Detection of hypocretin-1 and -2
US7544771B2 (en) Protein and its use in diagnosing Alzheimer's disease
AU2008200489B2 (en) Methods and compositions for the detection of soluble beta-amyloid peptide
AU722044B2 (en) Methods and compositions for the detection of soluble beta-amyloid peptide